Pneumonia (Adenovirus)

Overview

Plain-Language Overview

Pneumonia (Adenovirus) is an infection that affects the lungs, causing inflammation and difficulty breathing. It is caused by the adenovirus, a common virus that can also cause cold-like symptoms. This condition mainly affects the air sacs in the lungs, leading to symptoms such as cough, fever, and trouble breathing. The infection can range from mild to severe, especially in young children and people with weakened immune systems. The lungs may fill with fluid or pus, making it harder for oxygen to reach the bloodstream. This can cause fatigue and chest discomfort. Overall, it impacts the body's ability to get enough oxygen and fight off infection.

Clinical Definition

Pneumonia (Adenovirus) is an acute inflammation of the lung parenchyma caused by infection with adenovirus, a non-enveloped double-stranded DNA virus. The virus primarily targets the respiratory epithelium, leading to alveolar damage, interstitial inflammation, and impaired gas exchange. It is a significant cause of viral pneumonia in children and immunocompromised patients. Clinical features include fever, productive cough, dyspnea, and sometimes hypoxemia. Radiographically, it often presents with bilateral interstitial infiltrates or lobar consolidation. The disease can progress to respiratory failure or secondary bacterial pneumonia, making early recognition and supportive care critical. Diagnosis relies on identifying the virus in respiratory secretions.

Inciting Event

Inhalation of aerosolized respiratory secretions containing adenovirus initiates infection.
Exposure to contaminated fomites or surfaces can transmit adenovirus.
Close contact with an infected individual during the incubation period triggers disease onset.
Reactivation of latent adenovirus infection in immunosuppressed hosts can precipitate pneumonia.

Latency Period

Typical incubation period ranges from 2 to 14 days after exposure to adenovirus.
Symptom onset usually occurs within 5 to 7 days of initial infection.
Latency may be prolonged in immunocompromised patients, delaying clinical presentation.

Diagnostic Delay

Initial symptoms mimic common viral upper respiratory infections, leading to misdiagnosis as viral bronchitis.
Lack of routine adenovirus-specific testing delays identification of the causative agent.
Overlap with bacterial pneumonia symptoms often results in empiric antibiotic treatment before viral diagnosis.
Low clinical suspicion in adults contributes to delayed recognition of adenovirus pneumonia.

Patient Population

Children under 5 years are most commonly affected by adenovirus pneumonia.
Military recruits and young adults in communal living environments have higher incidence.
Immunocompromised patients are at risk for severe or disseminated adenovirus infection.
Outbreaks often occur in closed or institutional settings such as schools and dormitories.

Risk Factors

Close contact settings such as military barracks and daycare centers increase transmission risk.
Immunocompromised states including HIV, chemotherapy, or transplant recipients predispose to severe disease.
Young age, especially children under 5 years, is a major risk factor for symptomatic infection.
Crowded living conditions facilitate spread of adenovirus respiratory infections.
Underlying chronic lung disease such as asthma or cystic fibrosis increases susceptibility.

Clinical Presentation

Signs & Symptoms

High fever and nonproductive cough are hallmark symptoms.
Dyspnea and tachypnea reflect respiratory distress.
Pharyngitis and conjunctivitis often accompany adenovirus infection.
Chest pain may occur due to pleural involvement.
Fatigue and myalgias are common systemic symptoms.

History of Present Illness

Patients typically present with fever, nonproductive cough, and dyspnea progressing over several days.
Initial symptoms often include pharyngitis, conjunctivitis, and rhinorrhea before lower respiratory involvement.
Chest pain and wheezing may develop as pneumonia worsens.
Severe cases can progress to hypoxemia and respiratory distress requiring hospitalization.

Past Medical History

History of recent upper respiratory tract infection or exposure to infected contacts is common.
Prior immunosuppressive therapy or chronic illnesses increase risk of severe adenovirus pneumonia.
Previous episodes of viral pneumonia or recurrent respiratory infections may be relevant.
No specific genetic predisposition is typically noted in adenovirus pneumonia.

Family History

No well-established heritable syndromes are associated with adenovirus pneumonia susceptibility.
Family members may share exposure risks in household outbreaks but no genetic predisposition is identified.
No familial clustering of severe adenovirus pneumonia beyond shared environmental factors.

Physical Exam Findings

Fever and tachypnea are common in adenovirus pneumonia.
Crackles or rales on lung auscultation indicate alveolar involvement.
Decreased breath sounds may be present over areas of consolidation.
Hypoxia can be detected by low oxygen saturation on pulse oximetry.
Cervical lymphadenopathy may be noted due to viral infection.

Diagnostic Workup

Diagnostic Criteria

Diagnosis of adenoviral pneumonia is established by clinical presentation of fever, cough, and respiratory distress combined with radiographic evidence of pulmonary infiltrates. Confirmation requires detection of adenovirus in respiratory samples using PCR or viral culture. Chest X-ray typically shows bilateral interstitial or lobar infiltrates. Additional laboratory tests may show leukocytosis or elevated inflammatory markers but are nonspecific. Viral antigen detection or serology can support diagnosis but are less commonly used.

Pathophysiology

Key Mechanisms

Infection of respiratory epithelial cells by adenovirus leads to direct cytopathic effects and cell lysis.
Host immune response causes inflammation and alveolar damage contributing to impaired gas exchange.
Necrotizing bronchitis and bronchiolitis result from viral replication and immune-mediated injury.
Disruption of the mucociliary clearance facilitates secondary bacterial superinfection.
Formation of hyaline membranes and alveolar edema can occur in severe cases, resembling acute respiratory distress syndrome.

Involvement	Details
Organs	Lungs are the main organs affected, with adenovirus causing inflammation, consolidation, and impaired oxygenation.
Organs	Lymph nodes may become reactive due to immune activation during adenoviral infection.
Tissues	Respiratory epithelium is the primary site of adenovirus infection and damage, leading to impaired mucociliary clearance.
Tissues	Alveolar tissue undergoes inflammation and edema, contributing to impaired gas exchange in pneumonia.
Cells	Alveolar macrophages play a key role in phagocytosing adenovirus-infected cells and initiating the immune response.
	Cytotoxic T lymphocytes are critical for clearing adenovirus-infected respiratory epithelial cells.
	Neutrophils contribute to inflammation and tissue damage during adenoviral pneumonia.
Chemical Mediators	Interleukin-6 (IL-6) is elevated and mediates systemic inflammatory response and fever.
	Tumor necrosis factor-alpha (TNF-α) promotes local inflammation and recruitment of immune cells to infected lung tissue.
	Interferon-gamma (IFN-γ) enhances antiviral immunity by activating macrophages and promoting viral clearance.

Treatments

Pharmacological Treatments

Supportive care
- Mechanism:
  - Symptomatic relief through hydration, antipyretics, and oxygen supplementation to maintain adequate oxygenation.
- Side effects:
  - None specific to supportive care
- Clinical role:
  - First-line
Cidofovir
- Mechanism:
  - Inhibits viral DNA polymerase, reducing adenovirus replication.
- Side effects:
  - Nephrotoxicity
  - Neutropenia
  - Electrolyte imbalances
- Clinical role:
  - Second-line

Non-pharmacological Treatments

Oxygen therapy to correct hypoxemia and support respiratory function.
Mechanical ventilation in cases of respiratory failure due to severe pneumonia.
Hydration and nutritional support to maintain systemic health during illness.

Prevention

Pharmacological Prevention

No specific antiviral prophylaxis is routinely recommended for adenovirus pneumonia.
Adenovirus vaccine is available for military recruits to prevent outbreaks.
Supportive care with antipyretics and hydration is standard.

Non-pharmacological Prevention

Hand hygiene and respiratory droplet precautions reduce transmission.
Isolation of infected patients prevents nosocomial spread.
Avoidance of crowded settings during outbreaks decreases infection risk.
Proper disinfection of surfaces limits viral persistence.

Outcome & Complications

Complications

Respiratory failure requiring mechanical ventilation is a serious complication.
Secondary bacterial pneumonia can develop after viral infection.
Bronchiolitis obliterans may occur as a post-infectious sequela.
Pulmonary fibrosis can result from severe or prolonged inflammation.
Disseminated adenovirus infection is possible in immunocompromised hosts.

Short-term Sequelae	Long-term Sequelae
Persistent cough and mild dyspnea may last weeks after acute illness. Transient hypoxemia can occur during recovery phase. Reactive airway disease or wheezing may develop post-infection.	Chronic lung disease such as bronchiolitis obliterans can develop. Pulmonary fibrosis may cause long-term respiratory impairment. Recurrent respiratory infections can occur due to airway damage.

Differential Diagnoses

Pneumonia (Adenovirus) versus Respiratory Syncytial Virus (RSV) Pneumonia

Pneumonia (Adenovirus)	Respiratory Syncytial Virus (RSV) Pneumonia
Can affect all ages but more common in children and young adults	Primarily affects infants and young children under 2 years
Caused by a non-enveloped double-stranded DNA virus	Caused by a paramyxovirus
Bilateral interstitial infiltrates with possible lobar consolidation	Hyperinflation with peribronchial thickening and patchy infiltrates
Positive PCR or viral culture for adenovirus	Positive rapid antigen test or PCR for RSV

Pneumonia (Adenovirus) versus Mycoplasma pneumoniae Pneumonia

Pneumonia (Adenovirus)	Mycoplasma pneumoniae Pneumonia
More common in children and young adults but can affect all ages	Common in school-aged children and young adults
Caused by a DNA virus	Caused by a bacterial pathogen lacking a cell wall
Often acute onset with high fever and pharyngitis	Gradual onset with prolonged cough and malaise
May show lobar consolidation or diffuse interstitial infiltrates	Patchy or diffuse interstitial infiltrates without lobar consolidation

Pneumonia (Adenovirus) versus Influenza Virus Pneumonia

Pneumonia (Adenovirus)	Influenza Virus Pneumonia
Can occur year-round without strong seasonal pattern	Seasonal outbreaks during winter months
Non-enveloped double-stranded DNA virus	Enveloped single-stranded RNA virus
Often presents with pharyngitis and conjunctivitis	Rapid onset with systemic symptoms including myalgia and headache
Positive adenovirus PCR or culture	Positive rapid influenza antigen or PCR test

Pneumonia (Adenovirus) versus Bacterial Pneumonia (Streptococcus pneumoniae)

Pneumonia (Adenovirus)	Bacterial Pneumonia (Streptococcus pneumoniae)
Non-bacterial DNA virus	Gram-positive encapsulated diplococcus
Often presents with nonproductive cough and pharyngitis	Abrupt onset with high fever, productive cough with purulent sputum
Interstitial or lobar infiltrates with possible bilateral involvement	Lobar consolidation typical
No response to antibiotics; supportive care is mainstay	Responds to beta-lactam antibiotics

Pneumonia (Adenovirus) versus Cytomegalovirus (CMV) Pneumonia

Pneumonia (Adenovirus)	Cytomegalovirus (CMV) Pneumonia
Can occur in immunocompetent hosts	Occurs mainly in immunocompromised patients
Positive adenovirus PCR or culture	Positive CMV PCR or pp65 antigenemia
Bilateral interstitial infiltrates with possible lobar consolidation	Diffuse bilateral ground-glass opacities and nodules